About Us

MPH is a venture capital firm that invests in innovative research-driven companies in the areas of biotechnology, therapeutics and vaccines. Founded in 2006, MPH is a subsidiary of Mitsubishi Tanabe Pharma Corporation (MTPC). By working with MPH, promising companies can gain access to the funding and industry expertise needed to bring state-of-the-art products to market.